Cleared Special

K052905 - MODIFICATION TO COULTER LH 750 HEMATOLOGY ANALYZER

K052905 is an FDA 510(k) clearance for MODIFICATION TO COULTER LH 750 HEMATOLO..., manufactured by Beckman Coulter, Inc.. The device is a Class 2 Hematology device with product code GKZ cleared through the Special 510(k) pathway after a 35-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2005
Decision
35d
Days
Class 2
Risk

K052905 is an FDA 510(k) clearance for the MODIFICATION TO COULTER LH 750 HEMATOLOGY ANALYZER. Classified as Counter, Differential Cell (product code GKZ), Class II - Special Controls.

Submitted by Beckman Coulter, Inc. (Miami, US). The FDA issued a Cleared decision on November 18, 2005 after a review of 35 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5220 - the FDA hematology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Beckman Coulter, Inc. devices

FDA 510(k) Submission Details - K052905

510(k) Number K052905 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 14, 2005
Decision Date November 18, 2005
Days to Decision 35 days
Submission Type Special
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
78d faster than avg
Panel avg: 113d · This submission: 35d
Pathway characteristics
Modification to existing cleared device.

GKZ Device Classification - Class 2, Special Controls

Product Code GKZ Counter, Differential Cell
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GKZ Counter, Differential Cell

All 295
Devices cleared under the same product code (GKZ) and FDA review panel - the closest regulatory comparables to K052905.
SYSMEX AUTOMATED HEMATOLOGY ANALYZER MODELS XS SERIES
K060656 · Sysmex America, Inc. · May 2006
ABX MICROS CRP 200, OPTION IM
K053308 · Horiba Abx · Dec 2005
CHEMPAQ XBC ANALYZER
K050758 · Chempaq A/S · Dec 2005
SYSMEX MODEL XE-2100DC AUTOMATED HEMATOLOGY ANALYZER
K051459 · Sysmex America, Inc. · Sep 2005
MS 4/5 HEMATOLOGY ANALYZER
K050421 · Melet Schloesing Laboratories USA · Aug 2005
IPF (IMMATURE PLATELET FRACTION) PARAMETER ON THE SYSMEX MODEL XE-2100 AUTOMATED HEMATOLOGY ANALYZER
K051199 · Sysmex America, Inc. · Aug 2005